-
Mashup Score: 1Cancer Vaccine Development: ImmunoMedicine: Vol 1, No 1 - 3 year(s) ago
Click on the title to browse this issue
Source: Wiley Online LibraryCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 1Cancer Vaccine Development: ImmunoMedicine: Vol 1, No 1 - 3 year(s) ago
Click on the title to browse this issue
Source: Wiley Online LibraryCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
The first issue of ImmunoMedicine, a new #OpenAccess journal, is available now! Issue 1 is a special issue on #CancerVaccine Development. Read it now: https://t.co/DssNDXx4uy https://t.co/GDLuyRSXYO
-
-
Mashup Score: 8
A cancer vaccine could be an effective way to prevent cancer from evolving and becoming resistant to treatment, new research suggests.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet-
##Cancervaccine could be effective way to overcome treatment resistance @icrnews @NatureComms https://t.co/R2vI2miewB
-
-
Mashup Score: 0PPARa agonist fenofibrate enhances cancer vaccine efficacy - 3 year(s) ago
Reducing metabolic stress within the tumor microenvironment (TME) could be essential for improving the efficacy of cancer immunotherapy. Using a mouse model of melanoma, we show here that appropriately timed treatment with the PPARa agonist fenofibrate improves the ability of a T cell-inducing cancer vaccine to delay tumor progression. Fenofibrate reduced the use of glucose by tumor and stromal…
Source: Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Manipulating cancer cell and tumor-infiltrating lymphocyte metabolism with PPARα agonist #fenofibrate enhances #CancerVaccine efficacy in melanoma. https://t.co/Pe8xJdxwiN https://t.co/3a5WwzOium
-
-
Mashup Score: 1Personalized Vaccine Targets Bladder Cancer - 3 year(s) ago
New research reveals promising results for a new personalized vaccine for multiple cancer types, including bladder cancer.
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Personalized Vaccine Targets Bladder Cancer New research from @MountSinaiNYC shows promise for a new personalized vaccine for multiple cancer types, including #bladdercancer. See how this new treatment could help you: https://t.co/9PX1dbwZQm #cancervaccine #cancerresearch https://t.co/Hnb51Em3p3
-
-
Mashup Score: 2COVID-19 Jumpstarts RNA Cancer Vaccine Field - 3 year(s) ago
The success of the COVID-19 vaccines based on messenger RNA has led to a surge of interest from investigators, pharmaceutical companies, and investors in similar technology for other diseases, including a number of oncology indications.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#COVID-19 Jumpstarts RNA Cancer Vaccine Field #COVIDvaccine #cancervaccine https://t.co/7igVtgbH8C
-
-
Mashup Score: 1Small change makes cancer vaccine more effective in animal tests - 4 year(s) ago
Jefferson researchers developing a cancer vaccine to prevent recurrences of gastric, pancreatic, esophageal and colon cancers have added a component that would make the vaccine more effective. The change makes the vaccine less prone to being cleared by the immune system before it can generate immunity against the tumor components. The preclinical studies pave the way for a phase II clinical trial…
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet-
Small change makes ##cancervaccine more effective in animal tests https://t.co/uWFLcGfwHw
-
-
Mashup Score: 0
A personalised cancer vaccine, used in combination with an immunotherapy drug, triggers a response from the immune system that is specific to the cancer and shows some clinical benefit, according to the results of an early clinical trial presented at the virtual AACR conference.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
1️⃣ A personalised #CancerVaccine showed promise in an early #ClinicalTrial. #AACR20 #Immuntherapy https://t.co/4Um6bDnHGO
-
-
Mashup Score: 0
A personalized cancer vaccine combination with the PD-L1 inhibitor atezolizumab has shown clinical benefit in patients with advanced solid malignancies
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A personalized #cancervaccine, RO7198457, has shown promise for #solidtumors in combination with atezolizumab. The results from the Phase Ib clinical trial have been presented at #AACR20. Read the full story on @OncologyCentral now! https://t.co/NIXhlEBfFO
-
Check out the first issue of ImmunoMedicine, a new #OpenAccess journal, available now! Issue 1 is a special issue on #CancerVaccine Development. Read it now: https://t.co/1fqc5EANGB https://t.co/x27YIZqYdq